PureTech Health (PRTC) EBT Margin (2024 - 2025)

PureTech Health (PRTC) reported EBT Margin of 2369.48% for Q2 2025, up 1673816.0% year-over-year from N/an in Q2 2024, and up 87.6% quarter-over-quarter from 19107.64% in Q4 2024.

PureTech Health (PRTC) EBT Margin (2024 - 2025) Analysis & Trends

PureTech Health (PRTC) has 2 years of EBT Margin data on file, last reported at 2369.48% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 PureTech Health 86.36 Mn -190.94 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -2,369.48%
Dec 31, 2024 -19,107.64%
Jun 30, 2024 -19,107.64%